𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Reactivation of Kaposi's sarcoma-associated herpesvirus by natural products from Kaposi's sarcoma endemic regions

✍ Scribed by Denise Whitby; Vickie A. Marshall; Rachel K. Bagni; Wendell J. Miley; Thomas G. McCloud; Rebecca Hines-Boykin; James J. Goedert; Betty A.Conde; Kunio Nagashima; Judy Mikovits; Dirk P. Dittmer; David J. Newman


Publisher
John Wiley and Sons
Year
2006
Tongue
French
Weight
811 KB
Volume
120
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Kaposi's sarcoma (KS) and its causative agent, Kaposi's sarcoma associated herpesvirus (KSHV/HHV‐8), a gamma2 herpesvirus, have distinctive geographical distributions that are largely unexplained. We propose the “oncoweed” hypothesis to explain these differences, namely that environmental cofactors present in KS endemic regions cause frequent reactivation of KSHV in infected subjects, leading to increased viral shedding and transmission leading to increased prevalence of KSHV infection as well as high viral load levels and antibody titers. Reactivation also plays a role in the pathogenesis of KSHV‐associated malignancies. To test this hypothesis, we employed an in vitro KSHV reactivation assay that measured increases in KSHV viral load in KSHV infected primary effusion lymphoma (PEL) cells and screened aqueous natural product extracts from KS endemic regions. Of 4,842 extracts from 38 countries, 184 (5%) caused KSHV reactivation. Extracts that caused reactivation came from a wide variety of plant families, and extracts from Africa, where KSHV is highly prevalent, caused the greatest level of reactivation. Time course experiments were performed using 28 extracts that caused the highest levels of reactivation. The specificity of the effects on viral replication was examined using transcriptional profiling of all viral mRNAs. The array data indicated that the natural extracts caused an ordered cascade of lytic replication similar to that seen after induction with synthetic activators. These in vitro data provide support for the “oncoweed” hypothesis by demonstrating basic biological plausibility. © 2006 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Vertical transmission of Kaposi's sarcom
✍ Hamakwa Mantina; Chipepo Kankasa; Winslow Klaskala; Brad Brayfield; James Campbe 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 72 KB

Little is presently known about the specific routes of transmission of Kaposi's sarcoma-associated herpesvirus (KSHV) or human herpesvirus-8 (HHV-8). To investigate whether this agent might be transmitted vertically from mother to infant, we conducted a study on 89 KSHV seropositive mothers and thei

Molecular epidemiology of Kaposi's sarco
✍ Elena Kadyrova; Vincent Lacoste; Renan Duprez; Kazimir Pozharissky; Vladimir Mol 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 280 KB

## Abstract We report the molecular characterization of 38 new Kaposi's sarcoma‐associated herpesvirus (KSHV) strains from Russian patients with either classic (25 cases), epidemic/AIDS‐associated (7 cases), or posttransplant/immunosuppressed patients (6 cases), or Kaposi's sarcoma (KS). While a co

Minimal reactivation of Kaposi's sarcoma
✍ J. Paul Zoeteweij; Andrea S. Rinderknecht; David A. Davis; Robert Yarchoan; Andr 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB

## Abstract Corticosteroid use in transplant recipients increases the incidence and severity of Kaposi's sarcoma (KS), a disease associated with KS‐associated herpesvirus (KSHV) infection. Recently, the prototypic corticosteroid, hydrocortisone, was shown to directly induce lytic cycle reactivation

HIV-1 infection of primary effusion lymp
✍ Rastine Merat; Ali Amara; Celeste Lebbe; Hugues de The; Patrice Morel; Ali Saib 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 238 KB

## Abstract Kaposi's sarcoma‐associated herpesvirus (KSHV) is a gammaherpesvirus etiologically linked to primary effusion lymphoma (PEL), to a subset of multicentric Castleman's disease and to Kaposi's sarcoma (KS), the most common neoplasm associated with AIDS. Among KSHV‐infected individuals, the

Killing of Kaposi's sarcoma-associated h
✍ Nick C. Matthews; Martin R. Goodier; Rebecca C. Robey; Mark Bower; Frances M. Go 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 429 KB

## Abstract Kaposi's sarcoma-associated herpesvirus (KSHV) establishes life-long infection by evading clearance by the host immune system. In de novo infection and lytic replication, KSHV escapes cytotoxic T cells and NK cells through downregulation of MHC class-I and ICAM-1 molecules and associate

Seroprevalence of Kaposi's sarcoma-assoc
✍ Bishi Fu; Feng Sun; Baolin Li; Lei Yang; Yan Zeng; Xiulian Sun; Fanhong Xu; Simo 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB

## Abstract Xinjiang, China is an endemic area for Kaposi's sarcoma (KS) but the seroprevalence of Kaposi's sarcoma‐associated herpesvirus (KSHV) and risk factors remain undefined. In this study, antibodies to one KSHV latent protein (ORF73) and two KSHV lytic proteins (ORF65 and ORF‐K8.1) were exa